Clinical evaluation of a method for detecting superficial transitional cell carcinoma of the bladder by light-induced fluorescence of protoporphyrin ix following topical application of 5-aminolevulinic acid: Preliminary results

Lasers in Surgery and Medicine

Volumn 20, Issue 4, 1997, Pages 402-408

  Jichlinski, Patrice ^a,b,c   Forrer, Martin ^a,b,c   Mizeret, Jérôme ^a,b,c   Glanzmann, Thomas ^a,b,c   Braichotte, Daniel ^a,b,c   Wagnières, Georges ^a,b,c   Zimmer, Georges ^a,b,c   Guillou, Louis ^a,b,c   Schmidlin, Franz ^a,b,c   Graber, Peter ^a,b,c   Van Bergh, Hubert Den ^a,b,c   Leisinger, Hans Jürg ^a,b,c  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITY INSTITUTE OF PATHOLOGY   (Switzerland)

^c CHUG Hospital   (Switzerland)

Author keywords

5 aminolevulinic acid; Bladder neoplasms; Fluorescence, lif; Photodetection; Protoporphyrin ix; Transitional cell carcinoma

Indexed keywords

AMINOLEVULINIC ACID; PHOTOSENSITIZING AGENT; PROTOPORPHYRIN;

ADULT; AGED; ARTICLE; BLADDER BIOPSY; BLADDER CARCINOMA; BLADDER MUCOSA; CANCER DIAGNOSIS; CARCINOMA IN SITU; CLINICAL ARTICLE; CYSTOSCOPY; FEMALE; FLUORESCENCE; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; TOPICAL DRUG ADMINISTRATION; TRANSITIONAL CELL CARCINOMA;

ADMINISTRATION, CUTANEOUS; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; AMINOLEVULINIC ACID; CARCINOMA, TRANSITIONAL CELL; EVALUATION STUDIES; FEMALE; FLUORESCENCE; HUMANS; MALE; MIDDLE AGED; PHOTOFLUOROGRAPHY; PHOTOSENSITIZING AGENTS; PROTOPORPHYRINS; URINARY BLADDER NEOPLASMS;

EID: 17544400078     PISSN: 01968092     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9101(1997)20:4<402::AID-LSM5>3.0.CO;2-U     Document Type: Article

References (24)

1. Witjes JA, Kiemeney LALM, Oosterhof GON, Debruyne FMJ. Prognostic factors in superficial bladder cancer. Eur Urol 1992; 21:89-97.
2. Hofstädter F. Urothelial atypia and dysplasia. In: Rathert P, Roth S, Soloway MS, eds. "Urinary Cytology." Berlin: Springer-Verlag, 1993, pp 47-51.
3. Vicente J, Chechile G, Algaba F. Value of in vivo mucosastaining test with Méthylène Blue in the diagnosis of pretumoral and tumoral lesions of the bladder. Eur Urol 1987; 13:15-16.
4. Benson RC Jr, Farrow GM, Kinsey JH, Cortese DA, Zincke H, Utz DC. Detection and localization of in situ carcinoma of the bladder with hematoporphyrin derivative. Mayo Clin Proc 1982; 57:548-555.
5. Baumgartner R, Hofstetter A, Jocham D, Kriegmair M, Stepp H, Unsold E. Photodynamic diagnosis in UrologyFirst clinical experiences with a new method for detection of early stage cancer. (Die photodynamische Diagnose in der Urologie-Erste klinische Erfahrungen mit einer neuen Methode zur Tumorfrühererkennung). Lasermedizin 1992; 8:16-21.
6. Kennedy JC, Pettier RH, Pross DC. Photodynamic Therapy With Endogenous Protoporphyrin IX: Basic principles and present clinical experience. J Photochem Photobiol B:Biol 1990; 6:143-148.
7. Kennedy JC, Pottier RH. Endogenous Protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. J Photochem Photobiol B:Biol 1992; 14:275-292.
8. Hua Z, Gibson SL, Foster TH, Hilf R. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. Cancer Res 1995; 55:1723-1731.
9. Kriegmair M, Baumgartner R, Knuechel R, et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. Urology 1994; 44(6):836-841.
10. Van Hillegersberg R, Van den Berg JWO, Kort WJ, Terpstra OT, Wilson JHP. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. Gastroenterology 1992; 103:647-651.
11. Divaris DXG, Kennedy JC, Pottier RH. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. AJP 1990; 136(4):891-897.
12. Forrer M, Glanzmann T, Mizeret J, et al. Fluorescence excitation and emission spectra of ALA induced protoporphyrin IX in normal and tumoral tissue of the human bladder. Proc SPIE 1994; 2324:84-88.
13. Kriegmair M, Baumgartner R, Lumper W, Riesenberg R, Stocker S, Hofstetter A. Fluorescence cystoscopy following intravesical instillation of aminolevulinic acid (ALA). J Urol 1993; 149:240A.
14. Wagnières G, Depeursinge Ch, Monnier Ph, et al. Photodetection of early cancer by laser induced fluorescence of a tumor-selective dye: Apparatus design and realization. SPIE, Bellingham, WA USA 1990; 1203:43-52.
15. Wagnières G, Braichotte D, Châtelain A, et al. Photodetection of early cancer in the .upper aerodigestive tract and the bronchi using Photofrin II and colorectal adenocarcinoma with fluoresceinated monoclonal antibodies. SPIE, Bellingham, WA 1991; 1525:219-236.
16. Monnier Ph, Savary M, Fontolliet Ch, et al. Photodetection and photodynamic therapy of "early" squamous cell carcinomas of the pharynx, oesophagus and tracheo-bronchial tree. Lasers Med Sci 1990; 5:149-169.
17. Mostofi FK, Sobin LH, Torloni H. Histological typing of urinary bladder tumours. In: World Health Organisation, ed. "International Histological Classification of Tumours." Geneva: 1973.
18. "UICC-TNM Classification of Malignant Tumours," 4th ed. Berlin: Springer-Verlag, 1992.
19. Nagy GK, Frable WJ, Murphy WM. Classification of premalignant urothelial abnormalities: A Delphi study of the National Bladder Cancer Collaborative Group A. In: Sommers SC, Rosen PP, eds. Norwalk, CT: Appleton, 1982, pp 219-233.
20. Levi F, La Vecchia G, Randimbison L, Francesschi S. In-cidence of infiltrating cancer following superficial bladder carcinoma. Int J Cancer 1993; 55:419-421.
21. Silver-man DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992; 6(1):1-30.
22. Abel PD. Follow-up of patients with "superficial" transitional cell carcinoma of the bladder: The case for a change in policy. Br J Urol 1993; 72:135-142.
23. Steinbach P, Kriegmair M, Baumgartner R, Hofstädter F, Knüchel R. Intravesical instillation of 5-aminolevulinic acid: The fluorescent metabolite is limited to urothelial cells. Urology 1994; 44(5):676-681.
24. Kiemeney LALM, Witjes JA, Heijbroek'RP, et al. Should random urothelial biopsies be taken from patients with primary superficial bladder cancer? A decision analysis. Br J Urol 1994; 73:164-171.